LUNGevity has lengthy been dedicated to accelerating precision drugs and guaranteeing affected person entry to it. Personalised drugs is extra vital than ever with the identification of recent biomarkers, improved testing strategies to detect recognized biomarkers, and the quickly evolving panorama of lung most cancers remedy.
“We are thrilled that Nikki Martin will be joining the LUNGevity team,” Andrea Ferris, president and CEO of the Basis, says. “With her industry experience and expertise, she will elevate our current work in precision medicine.”
As Director of Precision Medication Initiatives, Nikki will handle LUNGevity’s main precision drugs initiatives, together with the Take Purpose initiative. Take Purpose, which started in 2015, works to make sure that sufferers have entry to biomarker testing and that it’s reimbursed with a purpose to assist information their therapy choices in a well timed manner. Nikki may even spearhead relationship constructing to kind coalitions and break down silos to enhance affected person and healthcare supplier schooling and entry to precision medicines. With Nikki steering the progress of this initiative, LUNGevity will proceed to make constructive strides ahead in breaking down limitations to affected person entry to biomarker testing.
Nikki Martin has labored on healthcare points advocacy for greater than 15 years. Her years of expertise will probably be invaluable in her new position as she focuses on accelerating entry to personalised healthcare for lung most cancers sufferers. Previous to becoming a member of LUNGevity, Nikki labored in Alliance & Advocacy Relations at Genentech the place she championed consciousness of unmet wants and driving change within the affected person neighborhood. She led advocacy outreach round Subsequent Technology Sequencing and CMS’ 14-day rule and increasing collaboration between CME suppliers and advocacy teams on supplier and affected person schooling on shared choice making.
About LUNGevity Basis
LUNGevity is the nation’s main lung most cancers group investing in lifesaving, translational analysis and offering help companies and schooling for sufferers and caregivers. LUNGevity’s targets are three-fold: (1) speed up analysis to sufferers, (2) empower sufferers to be lively members of their therapy choices, and (three) take away limitations that sufferers face in accessing the appropriate remedies.
LUNGevity Basis is firmly dedicated to creating an instantaneous influence on rising high quality of life and survivorship of individuals with lung most cancers by accelerating analysis into early detection and simpler remedies, in addition to by offering neighborhood, help, and schooling for all these affected by the illness. LUNGevity’s complete sources embrace a medically vetted web site, a toll-free HELPLine in partnership with CancerCare®, a singular Lung Most cancers Navigator app, peer-to-peer mentoring for sufferers and caregivers (LUNGevity LifeLine), and survivorship conferences. LUNGevity additionally helps sufferers discover and navigate scientific trials by our Medical Trial Finder software, a Medical Trial Ambassador program, and participation with EmergingMed.
Our imaginative and prescient is a world the place nobody dies of lung most cancers. For extra details about LUNGevity Basis, a four-star Charity Navigator group, please go to www.LUNGevity.org.
About Lung Most cancers within the U.S.
About 1 in 16 Individuals will probably be identified with lung most cancers of their lifetime
Greater than 234,000 individuals within the U.S. will probably be identified with lung most cancers this 12 months
About 60%-65% of all new lung most cancers diagnoses are amongst individuals who have by no means smoked or are former people who smoke
Lung most cancers takes extra lives than the subsequent three main cancers (colorectal, breast, and prostate) mixed
Solely 19% of all individuals identified with lung most cancers will survive 5 years or extra, BUT if it is caught earlier than it spreads, the possibility of 5-year survival improves dramatically
View authentic content material with multimedia:http://www.prnewswire.com/news-releases/lungevity-foundation-strengthens-commitment-to-ensuring-lung-cancer-patients-have-optimal-care-300674766.html
SOURCE LUNGevity Basis